| n | Mean EQ-5D T1 | Mean EQ-5D T2 | Mean Then Test | Conventional change | Retrospective change | ICCa | Mean Recall Test | Recall bias | Response shift | ICCb |
---|---|---|---|---|---|---|---|---|---|---|---|
Total | 550c | 0.482 (SD 0.30) | 0.735 (SD 0.24) | 0.419 (SD 0.35) | 0.254 (SD 0.29) | 0.316 (SD 0.31) | 0.489* | 0.462 (SD 0.34) | −0.020 (SD 0.30) | − 0.063 (SD 0.31) | 0.681* |
Gender | |||||||||||
 Males | 308 | 0.500 (SD 0.31) | 0.741 (SD 0.25) | 0.450 (SD 0.36) | 0.242 (SD 0.31) | 0.292 (SD 0.33) | 0.545* | 0.506 (SD 0.35) | 0.007 (SD 0.31) | −0.050 (SD 0.30) | 0.705* |
 Females | 242 | 0.459 (SD 0.28) | 0.728 (SD 0.23) | 0.380 (SD 0.33) | 0.269 (0.26) | 0.348 (SD 0.30) | 0.391* | 0.405 (SD 0.33) | −0.054 (SD 0.29) | − 0.079 (SD 0.31) | 0.648* |
Age | |||||||||||
  < 65 years | 285 | 0.452 (SD 0.29) | 0.741 (SD 0.24) | 0.373 (SD 0.34) | 0.289 (SD 0.29) | 0.369 (SD 0.32) | 0.516* | 0.425 (SD 0.34) | −0.028 (SD 0.31) | − 0.080 (SD 0.30) | 0.749* |
 65+ years | 265 | 0.513 (SD 0.30) | 0.729 (SD 0.24) | 0.469 (SD 0.35) | 0.216 (SD 0.29) | 0.260 (SD 0.30) | 0.435* | 0.501 (SD 0.35) | −0.012 (SD 0.29) | − 0.044 (SD 0.31) | 0.608* |
Educational level1 | |||||||||||
 Low | 127 | 0.503 (SD 0.33) | 0.697 (SD 0.26) | 0.443 (SD 0.37) | 0.193 (SD 0.30) | 0.254 (SD 0.30) | 0.439* | 0.489 (SD 0.35) | −0.015 (SD 0.32) | − 0.060 (SD 0.32) | 0.661* |
 Middle | 214 | 0.492 (SD 0.30) | 0.740 (SD 0.25) | 0.406 (SD 0.350) | 0.248 (SD 0.30) | 0.334 (SD 0.30) | 0.458* | 0.451 (SD 0.36) | −0.041 (SD 0.32) | −0.086 (SD 0.31) | 0.717* |
 High | 199 | 0.447 (SD 0.27) | 0.752 (SD 0.23) | 0.403 (SD 0.34) | 0.305 (SD 0.26) | 0.349 (SD 0.33) | 0.543* | 0.448 (SD 0.33) | 0.012 (SD 0.26) | −0.044 (SD 0.28) | 0.650* |
Comorbidity status2 | |||||||||||
 No comorbidity | 231 | 0.499 (SD 0.28) | 0.784 (SD 0.24) | 0.437 (SD 0.33) | 0.285 (SD 0.28) | 0.347 (SD 0.31) | 0.532* | 0.480 (SD 0.32) | −0.019 (SD 0.30) | −0.062 (SD 0.29) | 0.736* |
 Comorbidity | 309 | 0.472 (SD 0.31) | 0.702 (SD 0.24) | 0.407 (SD 0.36) | 0.230 (SD 0.29) | 0.295 (SD 0.32) | 0.450* | 0.452 (SD 0.36) | −0.020 (SD 0.30) | −0.065 (SD 0.32) | 0.655* |
ISS3 | |||||||||||
 ISS < 16 | 513 | 0.493 (SD 0.29) | 0.741 (SD 0.24) | 0.433 (SD 0.34) | 0.248 (SD 0.29) | 0.308 (SD 0.31) | 0.503* | 0.474 (SD 0.34) | −0.019 (SD 0.30) | −0.060 (SD 0.30) | 0.670* |
 ISS > = 16 | 35 | 0.350 (SD 0.30) | 0.659 (SD 0.28) | 0.229 (SD 0.40) | 0.309 (SD 0.29) | 0.429 (SD 0.36) | 0.315* | 0.289 (SD 0.38) | −0.061 (SD 0.34) | −0.120 (SD 0.39) | 0.740* |
TBI | |||||||||||
 No TBI | 384 | 0.432 (SD 0.28) | 0.721 (SD 0.24) | 0.383 (SD 0.33) | 0.290 (SD 0.28) | 0.338 (SD 0.31) | 0.461* | 0.428 (SD 0.33) | −0.004 (SD 0.30) | −0.048 (SD 0.31) | 0.656* |
 TBI | 166 | 0.598 (SD 0.30) | 0.768 (SD 0.25) | 0.501 (SD 0.38) | 0.171 (SD 0.28) | 0.267 (SD 0.31) | 0.525* | 0.539 (SD 0.37) | −0.058 (SD 0.29) | −0.096 (SD 0.29) | 0.742* |
PTSD symptoms4d | |||||||||||
 No PTSD | 451 | 0.490 (SD 0.29) | 0.759 (SD 0.22) | 0.423 (SD 0.34) | 0.269 (SD 0.28) | 0.337 (SD 0.31) | 0.518* | 0.471 (SD 0.34) | −0.019 (SD 0.30) | −0.068 (SD 0.29) | 0.684* |
 PTSD | 41 | 0.345 (SD 0.35) | 0.487 (SD 0.35) | 0.270 (SD 0.43) | 0.142 (SD 0.41) | 0.216 (SD 0.35) | 0.294* | 0.252 (SD 0.36) | −0.093 (SD 0.37) | − 0.075 (SD 0.45) | 0.780* |